OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Capital Raises

Equity Capital Raises

Equity Transaction Chart

Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.

Week ended 07/14/2023

Week ended 07/14/2023

This Section is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Equity Commentary

Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.

Week ended 07/14/2023

The Week’s Only Closed Equity Transaction:

  • On July 13, 2023, Better Life Pharma (BETR: CSE)(BETRF: OTCQb), a biopharmaceutical company developing compounds for the treatment of neuropsychiatric disorders, closed a $170K non-brokered private placement of units.
  • The company sold 2.2M units at $.076 per unit.
  • Each unit has one common share and two five-year warrants with 50% exercise premiums. The warrants value accounted for 17% of the unit price, but the issue was well received by the market and traded to a premium of 2% over pre-announcement prices.
  • The transaction implies a market cap of $6.8M and an enterprise value of $8.5M. The company is pre-revenue, making revenue or EBITDA multiples not applicable.

Public vs. Private Raises: 

  • Both companies that raised capital this week are public. Both trade in Canada on the CSE and in the U.S. OTC.

Equity vs. Debt Cap Raises: 

  • Equity accounted for one capital raise this week and 3.3% of the funds raised.

Week ended 07/14/2023

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

Weekly Valuation Tracker

Viridian highlights a specific industry sector and provides a deep dive into valuation metrics and comparable company valuations for public companies operating in that sector.  The Weekly Valuation Tracker provides proprietary, actionable valuation data.

This week’s valuation tracker focuses on the 7 U.S. MSOs with market cap over $500M in the Viridian Value Tracker database in gauge the valuation impact of the 2nd earnings that have been released so far, Green Thumb (GTII: CSE), Curaleaf (CURA: CSE), and Trulieve.   

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.

Additional content is available to Premium and Enterprise users. Please purchase a higher tier membership to see more. 

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.